Polypeptide variants

1. A variant of a DNase parent, wherein the variant comprises one or both motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 25) or ASXNRSKG (SEQ ID NO: 26), wherein the variant comprises one or more substitution(s) compared to SEQ ID NO: 1, wherein the substitution is selected from the group consisting of: T1I, T1V, T1Y, T1M, T1E, G4N, T5F, T5C, P6V, P6G, S7D, S7T, K8V, S9K, S9Q, S9V, S9L, S9F, S9P, S9R, A10D, A10M, A10I, A10Q, A10V, A10L, A10K, Q12S, Q12V, Q12E, Q14M, Q14R, N16S, A17C, A17V, A17E, A17T, T19K, T19L, T19S, T19I, T19V, K21E, K21M, G24Y, S25P, S27N, S27I, S27M, S27D, S27V, S27F, S27A, S27C, S27L, S27E, G28L, Y29W, S30K, S30D, S30H, S30T, D32Q, I38V, I38M, Q40V, S42C, S42L, S42M, S42F, S42W, V49R, L51I, K52I, K52H, A55S, D56I, D56L, D56T, S57W, S57F, S57H, S57C, S57P, S57V, S57R, S57T, Y58A, Y58T, S59C, S59T, S59L, S59Q, S59V, S59K, S59R, S59M, S59I, S59H, N61D, P63A, T65L, T65I, T65V, T65R, T65K, S68V, S68I, S68W, S68Y, S68H, S68C, S68T, S68L, V76G, V76L, V76C, V76K, V76H, V76E, V76A, V76Y, V76N, V76M, V76R, V76F, T77N, T77Y, T77W, T77R, F78I, F78H, F78Y, F78C, T79G, T79R, N80K, S82L, S82E, S82K, S82R, S82H, D83C, D83F, D83L, L92T, A93G, E94N, G99S, S101D, S101A, S102M, S102L, S102V, S102A, S102K, S102T, S102R, T104P, T104A, T105V, T105I, K107L, K107C, K107R, K107H, K107S, K107M, K107E, K107A, K107D, Q109R, Q109S, A112S, S116D, S116R, S116Q, S116H, S116V, S116A, S116E, S116K, A125K, S126I, S126E, S126A, S126C, T127C, T127V, S130E, G132R, D135R, T138Q, W139R, R143E, R143K, S144Q, S144H, S144L, S144P, S144E, S144K, G145V, G145E, G145D, G145A, A147Q, A147W, A147S, G149S, K152H, K152R, S156C, S156G, S156K, S156R, S156T, S156A, T157S, Y159F, K160V, W161L, W161Y, G162Q, G162D, G162M, G162R, G162A, G162S, G162E, G162L, G162K, G162V, G162H, S164R, S164T, Q166D, S167M, S167L, S167F, S167W, S167E, S167A, S167Y, S167H, S167C, S1671, S167Q, S167V, S167T, S168V, S168E, S168D, S168L, K1705, K170L, K170F, K170R, T171D, T171E, T171A, T171C, A172G, A172S, L173T, L173A, L173V, Q174L, G175D, G175E, G175N, G175R, M176H, L177I, N178D, N178E, N178T, N178S, N178A, S179E, S181R, S181E, S181D, S181F, S181H, S181W, S181L, S181M, S181Y, S181Q, S181G, S181A, Y182M, Y182C, Y182K, Y182G, Y182A, Y182S, Y182V, Y182D, Y182Q, Y182F, Y182L, Y182N, Y1821, Y182E, Y182T and Y182W, wherein the variant has a sequence identity to the polypeptide shown in SEQ ID NO: 1 of at least 80% and the variant has DNase activity.

2. The variant of claim 1 , which has an improved stability, measured as half-life improvement factor, HIF, compared to the parent or compared to the DNase having the polypeptide shown in SEQ ID NO: 1.

3. The variant of claim 1 , wherein the variant has at least 85% but less than 100% sequence identity to the polypeptide shown in SEQ ID NO: 1.

4. The variant of claim 1 , wherein the total number of alterations compared to SEQ ID NO: 1 is 1-20 alterations.

5. A detergent composition comprising a variant of claim 1 .

6. The detergent composition of claim 5 , further comprising one or more detergent components.

7. The detergent composition of claim 5 , further comprising one or more additional enzymes selected from the group comprising proteases, amylases, lipases, cutinases, cellulases, endoglucanases, xyloglucanases, pectinases, pectin lyases, xanthanases, peroxidaes, haloperoxygenases, catalases and mannanases, or any mixture thereof.

8. The detergent composition of claim 6 , in form of a bar, a homogenous tablet, a tablet having two or more layers, a pouch having one or more compartments, a regular or compact powder, a granule, a paste, a gel, or a regular, compact or concentrated liquid.

9. A method for obtaining a DNase variant, comprising:

a) introducing into a parent DNase an alteration at one or more positions corresponding to positions 1, 4, 5, 6, 7, 8, 9, 10, 12, 14, 16, 17, 19, 21, 24, 25, 27, 28, 29, 30, 32, 38, 40, 42, 49, 51, 52, 55, 56, 57, 58, 59, 61, 63, 65, 68, 76, 77, 78, 79, 80, 82, 83, 92, 93, 94, 99, 101, 102, 104, 105, 107, 109, 112, 116, 125, 126, 127, 130, 132, 135, 138, 139, 143, 144, 145, 147, 149, 152, 156, 157, 159, 160, 161, 162, 164, 166, 167, 168, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 181 and 182 of SEQ ID NO 1, wherein the variant has DNase activity; and

b) recovering the variant.

10. The method of claim 9 , wherein the variant comprises 1-20 alterations compared to the polypeptide shown in SEQ ID NO: 1.

11. The method according to claim 9 , wherein the alteration is a substitution and wherein the substitution is selected from the group consisting of: T1I, T1L, T1V, T1F, T1Y, T1M, T1E, G4N, T5F, T5C, P6V, P6G, S7D, S7T, K8V, S9K, S9Q, S9V, S9L, S9F, S9P, S9R, A10D, A10M, A10I, A10Q, A10T, A10V, A10L, A10K, Q12S, Q12V, Q12E, Q14M, Q14R, N16S, A17C, A17V, A17E, A17T, A17S, T19K, T19N, T19L, T19S, T19I, T19V, K21Q, K21E, K21M, G24Y, S25P, S25T, S27N, S27I, S27M, S27D, S27T, S27V, S27F, S27A, S27C, S27L, S27E, G28L, Y29W, S30K, S30D, S30H, S30T, D32Q, I38V, I38M, Q40V, S42G, S42C, S42D, S42L, S42M, S42F, S42N, S42W, V49R, L51I, K52I, K52Q, K52H, A55S, D56I, D56L, D56T, S57W, S57Y, S57F, S57H, S57C, S57P, S57V, S57R, S57T, Y58A, Y58T, S59C, S59T, S59L, S59Q, S59V, S59K, S59R, S59M, S59I, S59H, N61D, P63A, T65L, T65I, T65V, T65R, T65K, S68V, S68I, S68W, S68K, S68Y, S68H, S68C, S68T, S68L, V76G, V76L, V76C, V76K, V76H, V76E, V76A, V76Y, V76N, V76M, V76R, V761, V76F, T77N, T77Y, T77W, T77R, F78L, F78I, F78H, F78V, F78Y, F78C, T79G, T79R, N80K, N80S, S82L, S82E, S82K, S82R, S82H, D83C, D83F, D83L, L92T, A93G, E94N, G99S, S101D, S101A, S102M, S102L, S102V, S102A, S102K, S102T, S102R, T104S, T104P, T104A, T105V, T1051, K107L, K107C, K107R, K107H, K107S, K107M, K107E, K107A, K107Q, K107D, Q109K, Q109R, Q109S, A1125, S116D, S116R, S116Q, S116H, S116V, S116A, S116E, S116K, A125K, S1261, S126E, S126A, S126C, T127C, T127V, T127S, S130E, G132R, D135R, T138Q, W139R, R143E, R143K, S144Q, S144H, S144A, S144L, S144P, S144E, S144K, G145V, G145E, G145D, G145A, A147H, A147R, A147K, A147Q, A147W, A147N, A147S, G149S, K152H, K152R, S156C, S156G, S156K, S156R, S156T, S156A, T157S, Y159H, Y159F, K160R, K160V, W161L, W161Y, G162Q, G162N, G162D, G162M, G162R, G162A, G162S, G162E, G162L, G162K, G162V, G162H, S164R, S164H, S164N, S164T, Q166D, S167M, S167L, S167F, S167W, S167E, S167A, S167Y, S167H, S167C, S1671, S167Q, S167V, S167T, S168V, S168E, S168D, S168L, K170S, K170L, K170F, K170R, T171D, T171E, T171N, T171A, T171S, T171C, A172G, A172S, L173T, L173A, L173V, Q174L, G175D, G175E, G175N, G175R, G175S, M176H, L1771, N178D, N178E, N178T, N178S, N178A, S179E, S181R, S181E, S181D, S1811, S181F, S181H, S181W, S181L, S181M, S181Y, S181Q, S181V, S181G, S181A, Y182M, Y182C, Y182K, Y182G, Y182A, Y182S, Y182V, Y182D, Y182Q, Y182F, Y182L, Y182N, Y1821, Y182E, Y182T and Y182W compared to the polypeptide shown in SEQ ID NO: 1.

12. The method according to claim 9 , wherein the DNase parent belongs to the GYS-clade and comprises one or both motifs [D/M/L][S/T]GYSR[D/N] (SEQ ID NO: 25) or ASXNRSKG (SEQ ID NO: 26).

13. The method of claim 9 , wherein the parent DNase is selected from the group of polypeptides:

a) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1,

b) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 2,

c) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 3,

d) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 4,

e) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 5,

f) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 6,

g) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 7,

h) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 8,

i) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 9,

j) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 10,

k) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 11,

l) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 12,

m) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 13,

n) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 14,

o) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 15,

p) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 16,

q) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 17,

r) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 18,

s) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 19,

t) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 20,

u) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 21,

v) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 22,

w) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 23, and

x) a polypeptide having at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 24.

14. The method of claim 9 , wherein the parent DNase is obtained from the Bacillus genus.

15. The method according to claim 9 , wherein the DNase variant has at least 80% sequence identity to the polypeptide shown in SEQ ID NO: 1.

16. A method, comprising,

exposing a textile or hard surface to the detergent composition of claim 5 , completing at least one wash cycle, and

optionally rinsing the textile or hard surface.